MedTrace Logo

Population-centered Risk- and Evidence-based Dental Inter-professional Care Team

NCT02312921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2016-08-09

No results posted yet for this study

Summary

The main goal of the payment and delivery system reform is to reduce disparities in oral health and dental care access of low-income mothers and children living in rural Oregon counties. The target population is children, pregnant women and new mothers enrolled in Oregon Health Plan (OHP) in rural Oregon.

Conditions

  • Dental Caries

Interventions

OTHER

PREDICT

Allied dental personnel provide screening and preventive services in community settings and case managers serve as patient navigators to arrange referrals of children who need dentist services. The intervention is paired with a compensation system for high performance (pay-for-performance) with efficient performance monitoring. PREDICT focuses on: 1) identifying eligible children and gaining caregiver consent for services in community settings (e.g., schools); 2) providing risk-based preventive and caries stabilization services efficiently at these settings; 3) providing curative care in dental clinics; and 4) incentivizing local delivery teams to meet performance benchmarks.

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • Advantage Dental Services, LLC

    lead INDUSTRY

Principal Investigators

  • Peter Milgrom, DDS · Advantage Dental Services, LLC

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-06-30
Completion
2019-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02312921 on ClinicalTrials.gov